NCT01149850 2024-09-19
Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Jonsson Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
13 trialsNCT00387400 2023-08-04
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Canadian Cancer Trials Group
Phase 1 Completed
NCT00492167 2022-03-07
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01234740 2018-04-17
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
City of Hope Medical Center
Phase 1 Completed
NCT00897663 2018-01-24
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Alliance for Clinical Trials in Oncology
Completed
NCT01172964 2017-11-09
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
City of Hope Medical Center
Phase 1 Completed
NCT01004523 2016-07-18
Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
Alliance for Clinical Trials in Oncology
Completed
NCT01553175 2016-07-14
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
Children's Oncology Group
Completed
NCT01493830 2016-07-11
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
Children's Oncology Group
Completed
NCT01387724 2016-05-18
Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
Children's Oncology Group
Completed
NCT01585389 2016-05-18
Studying Gene Expression and Location in Samples From Patients With Brain Tumors
Children's Oncology Group
Completed
NCT01358604 2016-04-15
Biomarkers in Samples From Young Patients With Neuroblastoma
Children's Oncology Group
Completed
NCT00424060 2012-09-24
Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed